GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Geratherm Medical AG (XTER:GME) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 07, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.


Competitive Comparison of Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Medical Devices subindustry, Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.



Geratherm Medical AG  (XTER:GME) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Geratherm Medical AG EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.


Geratherm Medical AG (XTER:GME) Business Description

Industry
Traded in Other Exchanges
Address
Fahrenheitstrasse 1, Geratal, DEU, 99331
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Executives
Dr. Gert Frank Supervisory Board
Christian Frick Board of Directors

Geratherm Medical AG (XTER:GME) Headlines

From GuruFocus

GameStop Announces Release Date for First Quarter Fiscal 2023 Results

By Business Wire Business Wire 05-30-2023

GameStop Discloses Second Quarter 2023 Results

By Marketwired 09-06-2023

GameStop Announces Resignation of CFO

By Marketwired 07-27-2023

GameStop Announces Release Date for First Quarter Fiscal 2022 Results

By Business Wire Business Wire 05-23-2022

GameStop's Bear Case Continues to Widen

By Muslim Farooque 07-25-2022

GameStop Launches Wallet for Cryptocurrencies and NFTs

By Business Wire Business Wire 05-23-2022

GameStop Appoints New Chief Operating Officer

By Business Wire Business Wire 05-16-2022